Xiaonan Zhang
- E-post:
- xiaonan.zhang@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 37 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 Uppsala
Biografi
Researcher (Docent) / Project leader
Main research focus: Finding and understanding mutations that cause cancer and pursue novel cancer therapeutic strategies by targeting cancer-specific vulnerabilities in cell-cycle inactive cancer cell populations. For more information please visit: https://www.scilifelab.se/researchers/xiaonan-zhang/.
RESEARCH FUNDING
- The Swedish Cancer Society
- Swedish Childhood Cancer Foundation
- Göran Gustafssons Stiftelse's large prize fund on Medicine
- Åke Wibergs Foundation
- Jeanssons Foundation
- Lena Wäppling's Foundation
- Robert Lundbergs Foundation
EDUCATIONAL BACKGROUND
- 2011-2015, Ph.D, Department of Oncology-Pathology /Cancer Centre Karolinska, Karolinska Institute, Sweden
- 2008 - 2010, M.Sc, Chalmers University of Technology, Sweden

Publikationer
Urval av publikationer
Ingår i International Journal of Molecular Sciences, 2024
- DOI för Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
- Ladda ner fulltext (pdf) av Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
Ingår i Signal Transduction and targeted Therapy, 2023
- DOI för Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
- Ladda ner fulltext (pdf) av Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Ingår i Cell Death and Disease, 2023
- DOI för Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
- Ladda ner fulltext (pdf) av Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Ingår i International Journal of Molecular Sciences, 2023
- DOI för Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
- Ladda ner fulltext (pdf) av Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Ingår i Biochemical Pharmacology, 2022
- DOI för Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
- Ladda ner fulltext (pdf) av Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
Ingår i Cancers, 2022
- DOI för Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
- Ladda ner fulltext (pdf) av Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
Ingår i International Journal of Molecular Sciences, 2021
- DOI för Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
- Ladda ner fulltext (pdf) av Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
Ingår i Oxidative Medicine and Cellular Longevity, s. 1-11, 2019
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage
Ingår i Biochemical Pharmacology, s. 291-301, 2018
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics
Ingår i Trends in Cancer, s. 657-663, 2016
Ingår i Nature Communications, s. 3295, 2014
Senaste publikationer
NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
Ingår i Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025
- DOI för NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
- Ladda ner fulltext (pdf) av NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
Ingår i EBioMedicine, 2024
- DOI för Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Ladda ner fulltext (pdf) av Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
Ingår i Interdisciplinary Medicine, 2024
- DOI för Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
- Ladda ner fulltext (pdf) av Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
Ingår i International Journal of Molecular Sciences, 2024
- DOI för Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
- Ladda ner fulltext (pdf) av Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
Ingår i Signal Transduction and targeted Therapy, 2023
- DOI för Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
- Ladda ner fulltext (pdf) av Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
Alla publikationer
Artiklar i tidskrift
NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
Ingår i Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025
- DOI för NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
- Ladda ner fulltext (pdf) av NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
Ingår i EBioMedicine, 2024
- DOI för Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Ladda ner fulltext (pdf) av Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
Ingår i Signal Transduction and targeted Therapy, 2023
- DOI för Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
- Ladda ner fulltext (pdf) av Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Ingår i Cell Death and Disease, 2023
- DOI för Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
- Ladda ner fulltext (pdf) av Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Ingår i Cancer Chemotherapy and Pharmacology, s. 303-315, 2023
Ingår i Biochemical Pharmacology, 2022
- DOI för Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
- Ladda ner fulltext (pdf) av Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
Ingår i Cancers, 2022
- DOI för Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
- Ladda ner fulltext (pdf) av Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
Ingår i International Journal of Molecular Sciences, 2021
- DOI för Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
- Ladda ner fulltext (pdf) av Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
UNC-45A Breaks MT Lattice Independent of its Effect on Non-Muscle Myosin II
Ingår i Journal of Cell Science, 2020
Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
- Ladda ner fulltext (pdf) av Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
Ingår i Cancer Letters, s. 70-83, 2019
Ingår i Oxidative Medicine and Cellular Longevity, s. 1-11, 2019
Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
Ingår i Biochimie, s. 46-54, 2019
Ingår i Cancer Biology & Therapy, s. 1304-1313, 2019
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage
Ingår i Biochemical Pharmacology, s. 291-301, 2018
Ingår i Science Translational Medicine, 2018
MYC is downregulated by a mitochondrial checkpoint mechanism
Ingår i Oncotarget, s. 90225-90237, 2017
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
Ingår i Journal of the National Cancer Institute, 2017
Ingår i Blood, s. 1475-1489, 2016
Ingår i Molecular Cancer Therapeutics, s. 1504-1516, 2015
Ingår i Cancer Research, 2015
Ingår i Cancer Research, 2015
Ingår i Nature Communications, s. 3295, 2014
Ingår i Autophagy, s. 57-69, 2014
Ingår i Molecular Pharmacology, s. 932-945, 2014
Ingår i Antioxidants and Redox Signaling, s. 2271-2285, 2014
Ingår i Cancer Research, 2014
Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress
Ingår i Journal of Biological Chemistry, s. 30664-30676, 2012
Ingår i European Journal of Cancer, s. 396-406, 2012
Artiklar, forskningsöversikt
Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
Ingår i Interdisciplinary Medicine, 2024
- DOI för Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
- Ladda ner fulltext (pdf) av Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
Ingår i International Journal of Molecular Sciences, 2024
- DOI för Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
- Ladda ner fulltext (pdf) av Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis
Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Ingår i International Journal of Molecular Sciences, 2023
- DOI för Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
- Ladda ner fulltext (pdf) av Quiescent Cancer Cells: A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
Ingår i Pharmaceuticals, 2021
- DOI för Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
- Ladda ner fulltext (pdf) av Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
Ingår i Cancers, 2020
- DOI för Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
- Ladda ner fulltext (pdf) av Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics
Ingår i Trends in Cancer, s. 657-663, 2016
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
Ingår i International Journal of Molecular Sciences, s. 27313-27326, 2015